Tedizolid Phosphate Oral Formulation 1 (Reference)

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Healthy

Phase 1

A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)

CompletedNCT06609161

Merck Sharp & Dohme LLCHealthy

Start: 2024-07-16End: 2024-08-08Updated: 2024-09-27

A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)

CompletedNCT06733688

Merck Sharp & Dohme LLCHealthy

Start: 2022-03-23End: 2022-04-15Updated: 2024-12-13